Singapore markets open in 37 minutes

Straits Times Index
3,330.81
+0.80(+0.02%)
S&P 500
5,352.96
-1.07(-0.02%)
Dow
38,886.17
+78.84(+0.20%)
Nasdaq
17,173.12
-14.78(-0.09%)
Bitcoin USD
70,803.89
-338.85(-0.48%)
CMC Crypto 200
1,476.25
-48.55(-3.18%)

GSK PLC (GS71.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR

Add to watchlist

19.12

-0.25

(-1.29%)

At close: 04:07PM CEST

All

Evening Standard
FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble
GSK shares are today’s major focus after the drugs giant’s defence against Zantac claims suffered a setback in a Delaware court. The FTSE 100 index is trading higher after Friday’s late rally by Wall Street markets was further boosted by this week’s prospect of an ECB interest rate cut. Other companies in the spotlight today include FTSE 250-listed Hollywood Bowl, having posted an 11% rise in half-year profits.
Yahoo Finance Video
GSK stock sinks after court allows Zantac lawsuits to proceed
Shares of Britain-based pharmaceutical company GSK plc (GSK) — formerly known as GlaxoSmithKline — are sliding in pre-market trading and into Monday's session open following a court ruling that has approved more than 70,000 lawsuits to go forward over heartburn medication Zantac's alleged links to cancer. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
Business Wire
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
PHILADELPHIA, June 03, 2024--Jemperli trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced dMMR rectal cancer